Trials / Completed
CompletedNCT04025346
To Evaluate the Efficacy of Capsimax on Metabolic Rate
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Efficacy of Capsimax on Metabolic Rate
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Vedic Lifesciences Pvt. Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
Capsimax™ is a proprietary Capsicum Extract that employs Beadlet Technology. In the previous study it has been used to investigate its effect in reducing body fat/weight and increase metabolic rate. In this study, Capsimax™ will be used to assess effect on Resting Energy Expenditure (REE) using Indirect Calorimetry.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Capsimax | 1 capsule to be taken before breakfast. |
| OTHER | Micro Crystalline Cellulose | 1 capsule to be taken before breakfast. |
Timeline
- Start date
- 2019-10-17
- Primary completion
- 2020-03-23
- Completion
- 2020-03-30
- First posted
- 2019-07-18
- Last updated
- 2020-08-27
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT04025346. Inclusion in this directory is not an endorsement.